Trials / Unknown
UnknownNCT04721509
Effect of Smartphone Based Telemedicine and Education in Patients With Type 1 Diabetes Mellitus
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 0 Months – 30 Years
- Healthy volunteers
- Not accepted
Summary
Objective: evaluation of effect of smartphone based telemedicine and education in patients with type 1 diabetes mellitus Outline: Among the patients with type 1 diabetes, the group with telemedicine and education using smartphone set as a experimental group and the group without those set as a control group, respectively. Sample size: experimental group (n=50), control group (n=50) Inclusion criteria: patients with type 1 diabetes with A1c\>8.0% Exclusion criteria: chronic disease, psychological disease, children aged under 12 with parents with psychological disease, athletics Method: We divide subjects as an experimental group and a control group by randomization, and they visit outpatient clinic every 12 weeks. We perform telemedicine and education with smartphone application to the experimental group every 2 weeks. We evaluate the effect of smartphone based telemedicine and education in patients with type 1 diabetes mellitus with checking A1c and checklist at baseline, 12 weeks and 24 weeks after starting of the research. Variables: A1c, satisfaction, knowledge, self-confidence, willing to continuing, quality of life, physical activity, drinking, smoking Primary endpoint: Improvement in HbA1c of experimental group Secondary endpoint: No improvement in HbA1c of control group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Experimental : Smartphone-based telemedicine with the app 'Songaree diabetes' | Experimental group: outpatient clinic and offline education every 12 weeks plus telemedicine and education with smartphone app 'Songaree diabetes' every 2 weeks for 24 weeks |
Timeline
- Start date
- 2021-02-01
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
- First posted
- 2021-01-22
- Last updated
- 2021-01-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04721509. Inclusion in this directory is not an endorsement.